Niche ECM Substrates Target researchers in biotech and pharma who seek extracellular matrix–like substrates for more predictive cell culture and drug development outcomes, highlighting Nanofiber Solutions' electrospun nanofiber platforms as superior to traditional TCPS.

Clinical Translation Gap Emphasize the high failure rate of TCPS-based drug screening and position the company as a solution to improve translational success, appealing to organizations aiming to reduce late-stage attrition and R&D waste.

Scaleable Platforms Promote the ability to start with standard multiwell plate formats and scale to larger configurations, catering to both early-stage experiments and larger preclinical studies.

Cost-Effective Partners Leverage the small team size and mid-range revenue to highlight a nimble, customer-focused partner for bespoke substrates, pilot projects, and rapid development cycles.

Bio-Industry Relevance Position the company within the broader biotech manufacturing ecosystem by linking electrospun substrates to drug discovery, tissue engineering, and model system reliability to attract collaborations with CROs and academic labs.